Stem cell collection and processing technology, Therapy

InGeneron is a clinical-stage biotechnology company focused on developing innovative cell-based therapies aimed at redefining orthopedic care. The company specializes in regenerative medicine, particularly through the use of adipose-derived regenerative cells (ADRCs), which are harvested from a patient's own fat tissue. InGeneron's proprietary Transpose® RT system allows for the rapid isolation and processing of these regenerative cells at the point of care, enabling same-day treatment. This technology is designed to provide an alternative to traditional pain management methods, such as corticosteroid injections and invasive surgeries, by utilizing the body's own healing capabilities to address chronic joint pain and other orthopedic conditions.

The company is committed to evidence-based practices and is actively conducting FDA-approved clinical trials to validate the safety and efficacy of its therapies. InGeneron's research has shown promising results in treating various orthopedic conditions, including rotator cuff tendinopathy, facet joint syndrome, and wrist osteoarthritis. Their approach not only aims to alleviate symptoms but also to promote tissue regeneration and healing, potentially offering long-term solutions for patients suffering from chronic pain and mobility issues. Through rigorous clinical research and a focus on ethical practices, InGeneron seeks to establish new therapeutic standards in regenerative medicine.

United States

InGeneron is a clinical-stage biotechnology company developing novel, safe, and evidence-based cell therapies. We are setting new therapeutic standards by enabling minimally invasive treatments that unlock the healing potential of each patient’s own regenerative cells processed at the point of care for same-day treatment. We currently focus on helping patients impacted by orthopedic conditions and are conducting several clinical trials to validate our technology as a disease-modifying treatment. Based on more than 20 years of research, InGeneron is dedicated to developing therapies supported by clinical evidence and approved by the FDA.

InGeneron

Company Details